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Abstract: Background: To investigate the factors predicting the onset
of major adverse cardiovascular events (MACEs) after primary
percutaneous coronary intervention for ST-segment elevation myocar-
dial infarction (STEMI) patients. Methods: Two hundred forty-eight
STEMI patients (61.4 6 10.8 years, 186 men) who underwent success-
ful primary percutaneous coronary intervention were enrolled. Patients
were followed-up for 1 year. Univariate, multivariate analyses, and
receiver operating characteristic curve analysis were performed to deter-
mine the factors predicting MACEs. Results: There were 36 patients
(14.5%) who experienced MACEs in the follow-up period. Multivariate
logistic regression analysis demonstrated that hemoglobin (HgB) (odds
ratio 5 0.972; 95% CI, 0.948–0.998; P 5 0.033), neutrophil/
lymphocyte ratio (NLR) (odds ratio 5 1.511; 95% CI, 1.148–1.987;
P 5 0.003), Global Registry of Acute Coronary Event score, and post-
procedure left ventricular ejection fraction (LVEF) were independent
predictors of MACEs. Further subgroup analysis showed higher NLR
(.8.61), Global Registry of Acute Coronary Event score (.167) and
lower HgB (,131 g/L) all show superior predictive value for patients
with relatively higher LVEF (.48%); moreover, the c-statistic of NLR
and HgB both exceed 0.7. However, among patients with lower LVEF
(#48%), higher NLR and lower HgB lost the ability for predicting 1 year
MACEs independently. In addition, abnormally higher NLR (.8) could
predict 1-month MACEs efﬁciently. Conclusions: In summary, among
STEMI patients, elevated NLR, decreased HgB level on admission both
predicted 1-year MACEs independently, especially for those with
relatively preserved LVEF (.48%). Besides, abnormally higher NLR
on admission should attract their attention for short-term MACEs.
Key Indexing Terms: STEMI; Major adverse cardiovascular events;
Hemoglobin; Neutrophil/lymphocyte ratio. [Am J Med Sci 2015;349
(6):493–498.]
F or patients with ST-segment elevation myocardial infarction(STEMI), to achieve full, early and sustained revasculariza-
tion lies at the core position of the whole therapy and largely
affects the subsequent treatment. Primary percutaneous
coronary intervention (pPCI) is usually the preferred reperfusion
strategy among patients presenting with STEMI without contra-
indications, in a timely manner.1,2 However, not all the STEMI
patients receiving pPCI could beneﬁt equally from the
emergency procedure. Thereby, this study was designed to
investigate the clinical variables predicting major adverse car-
diovascular events (MACEs) after pPCI for STEMI patients,
which included cardiovascular mortality, serious ventricular
arrhythmia, stroke and reinfarction.
METHODS
Inclusion and Exclusion Criteria
Patients were eligible for this study if they presented with
the onset of symptoms of STEMI: persistent chest pain
(.30 minutes), prolonged elevtrocardiogram (ECG) changes
(including ischemic ST-segment elevation in 2 or more contig-
uous leads and/or depression) and signiﬁcantly increased serum
myocardial enzyme concentrations.3
Exclusion criteria contains non-STEMI; secondary
hypertension or endocrine diseases such as thyroid dysfunc-
tion or adrenal cortical dysfunction; severe vascular heart
disease; a history of chronic hepatitis or cirrhosis; severe renal
insufﬁciency; known contraindication to statins, heparin,
aspirin, clopidogrel, contrast or glycoprotein IIb/IIIa inhibitor;
recent serious infections, connective tissue disease, malig-
nancy; active severe bleeding; signiﬁcant gastrointestinal or
genitourinary bleeding, major surgery or trauma (,6 weeks);
history of cerebrovascular attack (within 1 year) or cerebro-
vascular attack with a signiﬁcant residual neurologic deﬁcit;
no unambiguous ST-segment in the ECG before catheteriza-
tion, balloon angioplasty alone, rescue PCI, conservative
treatment without PCI, previous onset of ventricular ﬁbrilla-
tion, cardiogenic shock, untreated 3rd or advanced degree of
atrioventricular block, estimated life expectancy ,12 months
and incomplete clinical data.
Therapy Process
To begin with ﬁltering the data using the eligibility and
exclusion criteria, a total of 248 patients underwent successful
pPCI in the second Hospital of Tianjin Medical University, China
were enrolled between January 2011 and October 2013. All
patients were admitted to emergency room within 12 hours from
onset and were diagnosed deﬁnitely with STEMI. All patients
received aspirin (300 mg orally) and clopidogrel (600 or 300 mg
orally) plus standard heparin (initial 10,000 IU and boost as the
operation time prolonged). Postprocedure glycoprotein IIb/IIIa
antagonists were administered for at least 1 day. Twelve-lead
ECG was recorded on admission and 60 minutes after infarct-
related artery recanalization with speed at 25 mm/s and 1.0 mV/
10 mm calibration. Ultrasound scans were taken within 5 days
after PCI (median 3.6 days) with a commercially available
system. Echocardiographic analysis was performed by two
operators who were blinded to clinical, electrocardiographic
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TABLE 1. Basic clinical characteristics, laboratory examinations, electrocardiogram results, angiographic and procedural
characteristics
MACEs (N 5 36) Non-MACEs (N 5 212) P
Clinical characteristics
Age, yr 64.2 6 11.2 61.0 6 10.7 0.093
Female, n (%) 12 (33.3) 50 (23.6) 0.212
Heart rate, beats per min 79.4 6 14.1 72.9 6 12.9 0.006a
SBP, mm Hg 125.9 6 19.7 133.2 6 21.6 0.057
Anterior wall MI, n (%) 21 (58.3) 91 (42.9) 0.086
Killip’s classiﬁcation . I, n (%) 7 (19.4) 26 (12.3) 0.241
GRACE score 162 (145–182) 141 (123–162) 0.001a
Diabetes mellitus, n (%) 7 (19.4) 60 (28.3) 0.268
Hypertension, n (%) 20 (55.6) 110 (51.9) 0.684
Previous MI, n (%) 10 (27.8) 33 (15.6) 0.074
Lab examination
Hemoglobin, g/L 139.7 6 18.4 148.1 6 16.7 0.007a
NLR, 3109/L 7.04 6 2.09 6.23 6 1.49 0.031a
Platelet, 3109/L 240.3 6 61.5 228.8 6 53.6 0.298
Albumin, g/L 37.5 6 3.4 38.2 6 3.3 0.253
TC, mmol/L 4.78 6 0.83 4.64 6 0.87 0.368
HDL-C, mmol/L 0.94 6 0.21 0.88 6 0.16 0.134
LDL-C, mmol/L 3.14 6 0.61 3.09 6 0.72 0.681
TG, mmol/L 1.41 6 0.88 1.64 6 0.96 0.168
FBG, mmol/L 7.8 6 3.2 7.0 6 2.3 0.161
Creatinine, mmol/L 73.1 6 15.6 72.1 6 14.9 0.710
Uric acid, mmol/L 351.2 6 96.2 330.5 6 73.8 0.226
BUN, mmol/L 6.41 6 1.44 5.98 6 1.72 0.157
CK-MB, U/L 167 (64–247) 115 (41–211) 0.133
cTnI, ng/ml 27.5 (13.6–60.0) 15.5 (3.5–30.0) 0.004a
Treatment
ACEIs/ARBs, n (%) 29 (80.6) 178 (84.0) 0.611
b-blocker, n (%) 19 (52.8) 136 (64.2) 0.192
CCBs, n (%) 10 (27.8) 53 (25.0) 0.723
Statins, n (%) 30 (83.3) 189 (89.2) 0.315
Diuretics, n (%) 8 (22.2) 34 (16.0) 0.360
Echocardiogram
LVEDD, mm 50.8 6 4.3 49.5 6 3.8 0.081
LAD, mm 37.0 6 4.5 36.1 6 4.6 0.280
LVEF, % 43.4 6 8.7 48.7 6 7.1 0.001a
EA ratio 1.1 6 0.4 1.1 6 0.4 0.47
ST resolution ,70%, n (%) 24 (66.7) 125 (59.0) 0.383
PTWI, n (%) 10 (27.8) 54 (25.5) 0.770
VSWM, n (%) 26 (72.2) 130 (61.3) 0.211
Pathological Q-wave, n (%) 22 (61.1) 92 (43.4) 0.049
Angiographic and procedural characteristics
GENSINI 80 (42–91.5) 60 (37–84) 0.140
Culprit vessels, n (%)
LAD 22 (61.1) 93 (43.9)
LCX 2 (5.6) 24 (11.3)
RCA 12 (33.3) 95 (44.8) 0.143
Stent number 1.3 6 0.5 1.3 6 0.6 0.940
Total length of stents, mm 33.7 6 13.4 31.8 6 16.8 0.512
Time from onset, min 255 (180–480) 240 (180–318) 0.131
Data are n/N (%) or mean 6 standard deviation or median (25th to 75th percentile).
a P , 0.05.
ACEIs, angiotensin-converting enzyme inhibitors; ARB, angiotensin receptor blockers; BUN, blood urea nitrogen; CCBs, calcium channel
blockers; CK-MB, creatinine kinase MB; cTnI, cardiac Troponin I; FBG, fasting blood glucose; HDL-C, high density lipoprotein; LAD, left anterior
descending; LAD, left atrial diameter; LCX, left circumﬂex coronary artery; LDL-C, low-density lipoprotein; LVEDD, left ventricular end-diastolic
diameter; LVEF, left ventricular ejection fraction; MI, myocardial infarction; NLR, neutrophil/lymphocyte ratio; PTWI, preoperative T wave
inversion; RCA, right coronary artery; RVD, right ventricular diameter; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyeride; VSWM,
ventricular segmental wall motion.
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and angiographic data. All the images were obtained at a frame
rate of 60 to 90 frames per second. Conventional parasternal
short axis views at apical, basal and middle levels were obtained,
as well as apical 2-chamber, 3-chamber and 4-chamber views.
Three consecutive cardiac cycles were digitally stored for
subsequent analysis during breath hold. The parameters of 2D
echocardiography and Doppler were measured by standard
methods described as follows: using biplane Simpson’s method
for measuring left ventricular volumes and ejection fraction.
Volumes were expressed as indices by normalizing with body
surface area.4
All the patients received 1 year follow-up after pPCI
until death; in few cases, the occurrence of MACEs after index
admission were recorded; besides 1 year, 1 month was another
observational time point in the follow-up period. Based on
these, the authors stratiﬁed the patients into MACEs group and
non-MACEs group and tried to identify the independent
predictors of poor prognosis. Biochemical indicators were
measured: blood routine (including hemoglobin, neutrophil
counts and lymphocyte counts), coagulation routine, renal
function, myocardial enzyme on admission and hepatic func-
tion, lipid level, fast blood glucose on the 2nd day. GRACE
score of 6 months was also calculated on admission. The
authors further stratiﬁed the patients into 2 subgroups according
to the postprocedure left ventricular ejection fraction (LVEF)
according to the median value of LVEF.
Electrocardiogram Calculation
The sum ST-segment elevation (STE) was measured 40
ms after the J point, elevation in leads I, aVL, V1–V6 plus
depression in leads II, III, aVF in case of anterior myocardial
infarction (MI), whereas for nonanterior MI, STE equals leads
elevation in II, III, aVF plus depression in leads V1–V4. Sum
ST-segment resolution was calculated as sum of the STE on the
1st ECG minus the sum of the STE on the 2nd ECG divided by
the STE on the 1st ECG and expressed as a percentage.5
Statistical Strategy
Continuous data were presented as mean6 standard devi-
ation or medians with interquartile ranges, whereas categorical
data as percentage, unless otherwise denoted. T test, Wilcoxon
rank-sum test and x2 test were used for qualitative and quantita-
tive variables to determine whether there is signiﬁcant difference
between MACEs and non-MACEs. Additionally, the authors
TABLE 2. Multivariate logistic regression analysis of predictor of MACEs
Variables B SE Wald P OR 95% CI
NLR 0.412 0.140 8.703 0.003a 1.511 1.148–1.987
LVEF 27.733 3.000 6.646 0.010a 0.000 0.000–0.157
Anterior wall MI 20.410 0.480 0.729 0.393 0.664 0.259–1.700
Hemoglobin 20.028 0.013 4.534 0.033a 0.972 0.948–0.998
Pathological Q-wave 0.708 0.440 2.590 0.108 2.029 0.857–4.803
Previous MI 0.659 0.501 1.731 0.188 1.933 0.724–5.158
GRACE 0.023 0.008 8.877 0.003a 1.024 1.008–1.039
LVEDD 0.032 0.059 0.291 0.590 1.032 0.920–1.158
cTnI 0.013 0.010 1.479 0.224 1.013 0.992–1.033
a Statistically signiﬁcant value (P , 0.05).
CI, conﬁdence interval; cTnI, cardiac Troponin I; LVEDD, left ventricular end diastolic diameter; LVEF, left ventricular ejection fraction; MI,
myocardial infarction; NLR, neutrophil/lymphocyte ratio; OR, odds ratio.
FIGURE 1. Receiver operating characteristic
curve of GRACE score and NLR for predicting
12 months MACEs after pPCI among STEMI
patients.
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performed the receiver operating characteristic (ROC) analysis to
identify the appropriate cutoff value of some effective predictive
indicators.6 The cutoff point they acquired lied at the maximum
sum of sensitivity and speciﬁcity. The variables selected to be
tested in the multivariate logistic regression analysis were those
with P , 0.1 in the univariate models. The adjusted odds ratio
and 95% conﬁdence interval were calculated. The ROC curves
were conducted with the Medcalc 12.3.0.0. All statistical tests
were 2-tailed, performed using SPSS 17.0 (SPSS, Inc, Chicago,
IL), and a P-value ,0.05 was considered statistically signiﬁcant.
RESULTS
Baseline Characteristics of Patients From
Individual Groups
Of the 248 enrolled patients, 36 (14.5%) suffered
MACEs in the 1-year follow-up, whereas 5 of whom died.
Among the MACEs group, 14 patients reached end point
within 1 month. One hundred twenty- patients presented with
an LVEF of exceeding 48% (54.2% 6 3.9%), whereas others
with relatively lower LVEF (42.0% 6 4.9%). Basic clinical
characteristics, laboratory examinations, electrocardiogram re-
sults, angiographic and procedural characteristics are depicted
in Table 1.
Signiﬁcant differences could be found between 2
groups in hemoglobin (HgB) (139.7 6 18.4 versus 148.1 6
16.7, P 5 0.007), neutrophil/lymphocyte ratio (NLR) (7.04 6
2.09 versus 6.23 6 1.49, P 5 0.031), LVEF (43.4% 6 8.7%
versus 48.7% 6 7.1%, P 5 0.001) and cardiac Troponin I
(cTnI) (P 5 0.004). There was an ascending trend of left
ventricular end diastolic diameter in MACEs group compared
with the non-MACEs group (50.8 6 4.3 versus 49.5 6 3.8,
P5 0.081). Previous PCI and anterior wall MI was more often
present in the MACEs group as compared with the other (P 5
0.074 and 0.086, respectively). Although not all the compo-
nents of Global Registry of Acute Coronary Events (GRACE)
score system perform their value in prognostic evaluation,
GRACE score was selected to represent the comprehensive
stress state, whose efﬁciency has been validated and compared
with thrombolysis in myocardial infarction (TIMI) STEMI
scores,7,8 consistent with their expectation, patients who suf-
fered from MACEs usually coincided with higher GRACE
score (P 5 0.001).
Multivariate Logistic Regression Analysis of
Predictor of MACEs
Through the multivariate regression analysis, high
GRACE score and NLR were independent predictors of MACEs
within 1 year after pPCI, along with low HgB concentration on
admission and low postprocedure LVEF (Table 2). The authors
conducted the ROC analysis but failed to ﬁnd any area under
curve (AUC) for 1-year MACEs exceeding 0.7 (Figures 1 and 2;
Table 3). Further subgroup analysis showed among 121 patients
with preserved LVEF (.48%), 13 suffered MACEs within 1
year, HgB, NLR and GRACE score all show their superior pre-
dictive value, although only the AUC of HgB and NLR exceed
0.7 (Table 3). However, among patients with lower LVEF
(#48%), neither the forecasting accuracy of HgB nor NLR main-
tained as the other subgroup presented (c-statistic 5 0.576 and
0.542, respectively; Table 3). Finally, when they focused on the
1-month MACEs among total patients, only NLR on admission
brought signiﬁcant predictive value for short-term prognosis after
pPCI (AUC 5 0.807, P , 0.0001).
DISCUSSION
The results showed relatively anemic state or excessive
inﬂammatory response both predict 1-year MACEs indepen-
dently, especially for those with relatively preserved LVEF
(.48%). In other words, the patients with higher postprocedure
LVEF were usually likely to be neglected of poor prognosis,
whereas based on the conclusion, HgB and NLR on admission
may provide extra risk stratiﬁcation for the very population.
Additionally, higher NLR prompt 1-month MACEs intensively.
Emergency PCI as soon as possible is the most effective
therapy in dealing with STEMI patients. As the most straight-
forward and valid coronary recanalization, pPCI could quickly
recover the coronary artery blood ﬂow, save the moribund
FIGURE 2. Receiver operating characteristic
curve of HgB and LVEF for predicting 12
months MACEs after pPCI among STEMI pa-
tients. HgB, hemoglobin; LVEF, left ventricular
ejection fraction; MACEs, major adverse car-
diovascular events and demonstrated pump
failure; NLR, neutrophil/lymphocyte ratio.
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myocardium, reduce infarction size and improve the prognosis.
However, a successful pPCI could not ensure the nonoccur-
rence of possible adverse cardiovascular events. The necrotic
myocardium in corresponding region participate in the pro-
gressive expansion and degeneration of left ventricle, along
with the left vulnerable endothelium, part of the patients may
suffer a serious of severe cardiovascular events during the
follow-up period.
The GRACE risk scores have been considered to have
higher predictive efﬁciency of MACEs in patients with
cardiovascular disease.9 However, other factors may also simul-
taneous inﬂuence the pronosis, apart from the stress state re-
ﬂected by GRACE score.
HgB concentration was not only powerful independent
determinant of poor prognosis for long-term10 and short-term11
observation but also help risk stratiﬁcation for acute coronary
syndrome patients.12 Although the exact mechanism is not
clear, the authors suppose the increased sympathetic release
and the activation of renin-angiotension-aldosteron system
induced by severe anemia may affect the hemodynamics, aggra-
vate the impaired cardiac function.13 Additionally, as a simple
index in blood routine, HgB could be expeditiously measured
when the patients were sent to emergency department, which
ensure its feasibility in clinical application of prognosis evalu-
ation. The relatively poor heart function in the observation
objects may be responsible for the lower cut-point of HgB when
compared with other research.14 A recent report indicated, for
STEMI patients, the longer delay before revascularization, the
lower admission HgB would be, which validate the relationship
between admission HgB level and prognosis from another per-
spective.15 Lower HgB admission was revealed that associated
with longer symptom duration and earlier inﬂammation
response, as well, closely correlated with worse prognosis and
elevated risk of MACEs during long-term follow-up.16 Another
potential explanation may be the relationship of lower HgB
concentration and higher likelihood of infection, which was
considered the most important inducement of pump failure.
Therefore, in patients with severe anemia listed for PCI, this
level of Hb should be considered as a precaution.
Abnormally elevated NLR on admission were proved to
be correlated with long-term prognosis in STEMI patients who
underwent pPCI.17 Results from several previous studies con-
ﬁrmed favorable value of preprocedure NLR in predicting
adverse outcomes including pump failure, cardiogenic shock,
severe ventricular arrythmias,18 stent thrombosis,19 angio-
graphic thrombus burden20 and long-term mortality21 among
STEMI patients, no matter whether pPCI was performed, and
even independent of GRACE risk score in patients with STE-
MI.22 Furthermore, Horne et al23 emphasized the predominant
predictive value of NLR in predicting death/MI among a serious
of hematological indices containing of neutrophil, lymphocyte
and NLR. NLR was also proved signiﬁcantly correlated with
angiographic severity of acute coronary syndrome24 and
GRACE risk score in STEMI patients.25 Besides, among coro-
nary artery disease patients, higher NLR usually indicate more
vulnerable plaque components, which is closely associated with
severe thrombus-related events.26
The conclusion further authenticate that although success-
ful pPCI were proceeded, the prognosis could also be inﬂuenced
by a serious of factors such as stress state when STEMI onset
(GRACE), whether excessive inﬂammation or severe anemia
exists. Patients in different risk stratiﬁcation should be assigned
with respectively reasonable medical resources. In the future
daily clinical work, the results above may help them to screen
patients with high risk, especially for those who presented
relatively considerable LVEF after pPCI. Additionally, differen-
tiating high-risk patients in short term from those with better
prognosis may also depend on NLR on admission.
TABLE 3. Univariate predictors of MACEs
Parameters AUC 95% CI P Threshold Sensitivity, % Speciﬁcity, %
Totala
HgB, g/L 0.633 0.569–0.693 0.0149b 131 44.44 85.38
LVEF 0.669 0.596–0.737 0.0022b 47% 47.22 87.74
NLR 0.625 0.562–0.686 0.0542 8 52.78 90.57
GRACE 0.679 0.617–0.737 0.0003b 145 75.00 55.19
LVEF .48%a
HgB, g/L 0.784 0.700–0.854 0.0002b 131
NLR 0.776 0.691–0.847 0.0037b 8.61
GRACE 0.667 0.575–0.750 0.0461b 167
LVEF #48%a
HgB, g/L 0.576 0.485–0.663 0.2577 131
NLR 0.542 0.451–0.631 0.6192 7.91
GRACE 0.670 0.581–0.751 0.0083b 161
After pPCIc
HgB, g/L 0.563 0.499–0.626 0.4373 131
NLR 0.807 0.752–0.854 ,0.0001b 8
GRACE 0.648 0.585–0.708 0.0687 174
LVEF 0.658 0.595–0.717 0.0788 40%
a In 12 months for all enrolled patients.
b Statistically signiﬁcant value (P , 0.05).
c In 1 month for all enrolled patients based on ROC.
AUC, area under curve; CI, conﬁdence interval; HgB, hemoglobin; LVEF, left ventricular ejection fraction; MACEs, major adverse
cardiovascular events; NLR, neutrophil/lymphocyte ratio; pPCI, primary percutaneous coronary intervention; ROC, receiver operating characteristic.
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CONCLUSIONS
In summary, regarding STEMI patients, besides
GRACE risk score, elevated NLR, decreased HgB level on
admission both predicted 1-year MACEs independently,
especially for those with relatively preserved LVEF after
pPCI (.48%). As a strong inﬂammatory indicator, NLR could
predict 1-month MACEs with high efﬁcacy. In the future,
efforts are still warranted to identify these high-risk patients
to manage them with target as early as possible to obtain
further rehabilitation.
Limitations
Sample size from the single center was not large enough
to determine more accurate predicting threshold for both gender
respectively, especially for HgB, apart from this, the LVEF
decline degree could not be obtained from all the patients.
Additionally, NLR on different time point during hospitaliza-
tion should be analyzed separately and precisely, maybe, in
their further prospective cohort study. Finally, the follow-up
period could be elongated if possible to explore the predicting
of long-term prognosis.
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